SNOA Stock Summary and Trading Ideas (Sonoma Pharmaceuticals | NASDAQ:SNOA)

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.

Sonoma Pharmaceuticals trades on the NASDAQ stock market under the symbol SNOA.

As of April 26, 2024, SNOA stock price was flat at $0.16 with 104,026 million shares trading.

SNOA has a beta of 3.91, meaning it tends to be more sensitive to market movements. SNOA has a correlation of 0.11 to the broad based SPY ETF.

SNOA has a market cap of $2.48 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, SNOA stock traded as high as $13.36 and as low as $.12.

The top ETF exchange traded funds that SNOA belongs to (by Net Assets): VXF.

SNOA has underperformed the market in the last year with a price return of -84.3% while the SPY ETF gained +26.8%. SNOA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.4% and -5.3%, respectively, while the SPY returned +4.5% and -1.9%, respectively.

SNOA support price is $.15 and resistance is $.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNOA stock will trade within this expected range on the day.